Prolactinoma epidemiology and demographics

Revision as of 13:39, 21 July 2017 by Anmol Pitliya (talk | contribs)
Jump to navigation Jump to search

Prolactinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Prolactinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

ECG

X-ray

Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Prolactinoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Prolactinoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Prolactinoma epidemiology and demographics

CDC on Prolactinoma epidemiology and demographics

Prolactinoma epidemiology and demographics in the news

Blogs on Prolactinoma epidemiology and demographics

Directions to Hospitals Treating Prolactinoma

Risk calculators and risk factors for Prolactinoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: , Anmol Pitliya, M.B.B.S. M.D.[2], Faizan Sheraz, M.D. [3]

Overview

45% of pituitary adenoma are prolactinoma, making it the most common of all pituitary adenoma.[1]

The prevalence of prolactinoma in age group <20 years is 100 per 1,000,000 individuals worldwide.

Prolactinoma most commomly affects age group 20 to 50 years.

Prolactinoma is more common in females than males in age group 20 to 50 years. Frequency becomes similar after age 50 years.

Epidemiology and Demographics

Prevalence

  • Worldwide, the prevalence of sporadic prolactinoma is 6 to 10 per 100,000 persons.[1]
  • The prevalence of prolactinoma in age group <20 years is 100 per 1,000,000 individuals worldwide.
  • Clinically significant pituitary tumors affect the health of approximately 14 out of 100,000 people in United States.
  • Some growth hormone producing tumors also co-secrete prolactin.
  • Microprolactinoma are much more common than macroprolactinoma.

Incidence

  • Worldwide, the incidence of sporadic prolactinoma is 0.6 to 1.0 per 100,000 persons per year.[1]

Age

Age specific distribution of prolactinoma is as follows:[1][2]

  • Prolactinoma commonly affects individuals of age 20 to 50 years.
  • Prolactinoma occur less commonly in age <20 years with a prevalence of 100 per, 1,000,000 individuals. These tumors accounts for <2% of intracranial tumors among this age group.

Gender

  • women usually have microprolactinoma whereas men usually have macroadenoma.
  • Gender wise frequency of prolactinoma depends on age of individual:
    • Age group - 20 to 50 years
      • Women are more commonly affected by prolactinoma than men. The women to men ratio is approximately 10:1.[1]
      • The highest prevalance of prolactinoma in women is in age group 20 to 30 years with a women to men ratio of approximately 14:1.
    • Age group >50 years[2]
      • Men and women are affected equally after age 50 years.
      • Prevalance of prolactinoma increases with age in men after age 50 years which peaks during age group 60 to 70 years. At this time women to men ratio is 1:3.


References

  1. 1.0 1.1 1.2 1.3 1.4 Ciccarelli A, Daly AF, Beckers A (2005). "The epidemiology of prolactinomas". Pituitary. 8 (1): 3–6. doi:10.1007/s11102-005-5079-0. PMID 16411062.
  2. 2.0 2.1 Mindermann T, Wilson CB (1994). "Age-related and gender-related occurrence of pituitary adenomas". Clin Endocrinol (Oxf). 41 (3): 359–64. PMID 7893282.

Template:WikiDoc Sources